Background illustration for clinical trials search

Paid Clinical Trials Norwalk

Discover 1,132 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Valhalla NY, Stony Brook NY, New Haven CT, Mineola NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for
Metastatic Malignant Neoplasm in the Lung,
Location: Valhalla NY, Stony Brook NY, New Haven CT, The Bronx NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT05235165

Phase3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Valhalla NY, Stony Brook NY, New Haven CT, Mineola NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase3, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: Valhalla NY, New Haven CT, The Bronx NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase2, Recruiting

StrokeNet Thrombectomy Endovascular Platform

for
Ischemic Stroke
Location: Stony Brook NY, New Haven CT, The Bronx NY, New York NY,
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06289985

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Stony Brook NY, New Haven CT, New York NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

for
Peripartum Cardiomyopathy, Postpartum
Location: Stony Brook NY, New Haven CT, The Bronx NY, New York NY,
Sponsor: Dennis M. McNamara, MD, MS

Sex: Female

Age: 18+

Code: NCT05180773

Recruiting

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

for
Type B Aortic Dissection
Location: Stony Brook NY, Roslyn NY, New Haven CT, New York NY,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT06087029

Recruiting

The ArtixASCEND Study

for
Acute Lower Limb Arterial Occlusion
Location: Stony Brook NY, New Haven CT, Brooklyn NY,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT07135895

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Stony Brook NY, Mineola NY, The Bronx NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

for
Focal Epilepsy
Location: Stony Brook NY, Hawthorne NY, New Haven CT, Woodmere NY,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06132893

Phase2, Phase3, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Stony Brook NY, Commack NY, New Haven CT, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Stony Brook NY, New Haven CT, New Hyde Park NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Stony Brook NY, Commack NY, West Haven CT, Manhasset NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06317649

Phase2, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Stony Brook NY, Commack NY, West Haven CT, Manhasset NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase2, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Stony Brook NY, The Bronx NY, New York NY,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

for
Focal Seizures
Location: Hawthorne NY, New Haven CT, New Brunswick NJ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT07233239

Phase1, Recruiting

Daily Inclusion of Eggs in a Heart-Healthful Dietary Pattern in Hyperlipidemic Adults

for
Hyperlipidemias
Location: Derby CT
Sponsor: Griffin Hospital

Sex: All

Age: 18+

Code: NCT05807334

Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Derby CT, New Haven CT, North Haven CT, Guilford CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06465316

Phase1, Recruiting

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Derby CT, New Haven CT, Guilford CT, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06649812

Phase2, Recruiting